产品详情
Targets
Target | Value |
---|---|
EGFR | IC50: 38.5nM |
Src | IC50: 282nM |
MEK/ERK | IC50: 800nM |
ErbB2 | IC50: 1.255μM |
Raf | IC50: 3.353μM |
c-Met | IC50: 4.1μM |
CDK4 | IC50: >20μM |
In vitro | DMSO | 12 mg/mL (25.64 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.37 mL | 106.86 mL | 213.72 mL |
0.5 mM | 4.27 mL | 21.37 mL | 42.74 mL |
1 mM | 2.14 mL | 10.69 mL | 21.37 mL |
5 mM | 0.43 mL | 2.14 mL | 4.27 mL |
*The above data is based on the productmolecular weight 467.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10706 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 467.9 |
Formula | C24H23ClFN5O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 257933-82-7 |
Synonyms | WAY-EKB 569 |
SMILES | CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C |
产品标签
Product Questions
Product Questions
Erlotinib HCl
Erlotinib hydrochloride是一种可逆的酪氨酸激酶抑制剂,作用于表皮生长因子受体(EGFR)。
BMS 599626 (AC480)
BMS 599626 (AC480)是一种选择性的,高效效的HER1,HER2和HER4酪氨酸激酶抑制剂(IC50分别为22、32和190 nM),具有…
AZD-9291 (Osimertinib)
AZD-9291 (Osimertinib)是第三代EGFR抑制剂,在临床前研究中显示出希望,并为已对现有EGFR抑制剂产生耐药性的…
Lapatinib (free base)
Lapatinib (free base)是一种双重酪氨酸激酶抑制剂,是一种有效的EGFR和ErbB2抑制剂,在无细胞试验中IC50分别为1…